Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Otulfi™ (ustekinumab-aauz) – New biosimilar approval

September 30, 2024 - Formycon and Fresenius Kabi announced the FDA approval of Otulfi (ustekinumab-aauz), biosimilar to Janssen’s Stelara® (ustekinumab).

Download PDF

Rx navigation